does tirzepatide reduce inflammation and lupus: what SLE patients need to know Tirzepatide for Joint Pain &

Tirzepatide (Mounjaro) was recently approved for the treatment of diabetes and is expected to get the green light for weight loss in the coming months

266 SchmidtEKTorres-EspinARaposoPJMadsenKLKigerlKAPopovichPGet al

NICE guidance (NG28) recommends GLP-1 receptor agonists as a treatment option for adults with type 2 diabetes when: Triple therapy with metformin and two other oral drugs is not effective, not tolerated or contraindicated The person has a BMI of 35 kg/m or higher (adjust accordingly for people from particular ethnic groups) and specific psychological or other medical problems associated with obesity The person has a BMI lower than 35 kg/m and insulin would have significant occupational implications, or weight loss would benefit other significant obesity-related comorbidities GLP-1 receptor agonists may also be considered in combination with insulin therapy in specialist care settings Beyond glycaemic control, specific GLP-1 receptor agonists offer significant cardiovascular benefits

Ist Super Sanita 52, 205212

This is a key reason why prolonged fasting can lead to muscle loss